Thermo Fisher Scientific Inc
Diagnostics & Research
Healthcare
TMO
379 M shares
NYSE US
traded
23 Sep 2025
listed
no
open
471.12
52 week high
623.35
high
475.57
52 week low
0.00
low
467.28
growth
-23.40 %
previous Close
474.99
P/E ratio
91
market cap
162 B
div yield
0
usd
Mar 2025
qoq
revenue
10.36 B
-9.05 %
net incoming
1.51 B
-17.65 %
eps
5.15 %
-15.57 %
eps surprise
0.94 %
net profit margin
14.54 %
-1.00 %
operating incoming
1.72 B
-14.88 %
net change in cash
132 M
120.95 %
cash on hand
4.13 B
3.12 %
cost of revenue
6.13 B
-5.27 %
top top